Main > ENDOCRINOLOGY > HypoGlycemia > Treatment > TransFerrin Inhibitor. > AntiBody Type Inhibitor > Patent > Claims > Claim 1: Antagonizing TransFerrin > Inhibition Blood Glucose Metabolism > Regulated by Insulin in Mammal > Method: Adm. AntiBody that can Bind > TransFerrin at Conditions Suitable > to Modulate Blood Glucose Levels. > Claim 2: Monoclonal AntiBody. > Claim 3: Mammal: Human. Claim 4: > Oral Adm. Etc. Claim 5: > Human TransFerrin. Claim 6: > TransFerrin Select: Apo-TransFerrin > Etc. Patent Assignee
Etc. Patent Assignee's products
USA. C